Article 1

United Kingdom

This Regulation establishes, within the framework of decisions relating to marketing authorizations for medicinal products, certain detailed arrangements by which the Standing Committee on Medicinal Products for Human Use and the Standing Committee on Veterinary Medicinal Products (hereinafter collectively referred to as ‘the Committee’) shall implement the procedure laid down in Article 73 of Regulation (EEC) No 2309/93, Article 37 (b) of Council Directive 75/319/EEC^f1 and Article 42 (k) of Directive 81/851/EEC^f2.

Annotations

Footnotes

f1: OJ No L 147, 9. 6. 1975, p. 13.
f2: OJ No L 317, 6. 11. 1981, p. 1.

Notes on the whole EU Regulation

Textual amendments

F1: Regulation revoked in part (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 9 para. 1(c) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)